Share

October 2016; 3 (5) ArticleOpen Access

Optic neuropathy associated with systemic sarcoidosis

Desmond P. Kidd, Ben J. Burton, Elizabeth M. Graham, Gordon T. Plant
First published August 2, 2016, DOI: https://doi.org/10.1212/NXI.0000000000000270
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
2596

Share

Article Information

vol. 3 no. 5 e270
DOI: 
https://doi.org/10.1212/NXI.0000000000000270
PubMed: 
27536707
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received January 25, 2016
  • Accepted in final form June 27, 2016
  • First Published August 2, 2016.
Copyright & Usage: 
© 2016 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Desmond P. Kidd, MD,
    2. Ben J. Burton, FRCOphth,
    3. Elizabeth M. Graham, MD and
    4. Gordon T. Plant, MD
  1. Desmond P. Kidd, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Kidd D, Newman NJ, Biousse V. Neuro-ophthalmology. Elsevier 2008

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Ben J. Burton, FRCOphth,
    3. Scientific Advisory Boards:

    1. (2)Bayer (2)Novartis

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (2)Tavel and accomodation and registration fees from Novartis and Bayer

    Editorial Boards:

    1. (1)Eastern European Journal of Neurology. Sub Editor 2015-

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1)Luminous Study, Octave Study, Safari Study - Novartis ALCON/Novartis RTH258 Phase III Iris Study - Alimeira Eylea study - Bayer Candle Study - Polyphotonics

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Elizabeth M. Graham, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Gordon T. Plant, MD
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal name: Neuro-Ophthalmology Role: Editor in Chief since 2007 No compensation

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neuro-ophthalmology (D.P.K., B.J.B., E.M.G., G.T.P.), the National Hospital for Neurology and Neurosurgery, The Royal Free Hospital, St Thomas' Hospital, London; James Paget University Hospital (B.J.B.), Great Yarmouth; and University of East Anglia (B.J.B.), Norwich, UK.
  1. Correspondence to Dr. Kidd: d.kidd{at}ucl.ac.uk
View Full Text

Article usage

Article usage: August 2016 to August 2020

AbstractFullPdfSource
Aug 201631847264Highwire
Aug 201603126pmc
Sep 201629411452Highwire
Sep 201604728pmc
Oct 20163757374Highwire
Oct 201606022pmc
Nov 20168935826Highwire
Nov 201607324pmc
Dec 2016432615Highwire
Dec 201605012pmc
Jan 2017751822Highwire
Jan 201709517pmc
Feb 2017251713Highwire
Feb 2017011615pmc
Mar 2017302613Highwire
Mar 2017015019pmc
Apr 2017191113Highwire
Apr 201714105115pmc
May 201730117Highwire
May 201725143158pmc
Jun 201717176Highwire
Jun 201726137151pmc
Jul 201720136Highwire
Jul 201722128139pmc
Aug 201715104Highwire
Aug 201712132156pmc
Sep 20171696Highwire
Sep 201719134147pmc
Oct 201723147Highwire
Oct 201723159189pmc
Nov 2017121910Highwire
Nov 201716137159pmc
Dec 201712618Highwire
Jan 20182374Highwire
Feb 20184275Highwire
Mar 20180337Highwire
Apr 20181319Highwire
Apr 20189113130pmc
May 201815616Highwire
Jun 20180519Highwire
Jun 201811127131pmc
Jul 20182649Highwire
Aug 201811178Highwire
Aug 201817148185pmc
Sep 201807421Highwire
Oct 20183737Highwire
Nov 201831368Highwire
Dec 201802559Highwire
Jan 201942075Highwire
Feb 20191116111Highwire
Mar 2019810312Highwire
Apr 201945614Highwire
May 20198458Highwire
Jun 201957418Highwire
Jul 201969321Highwire
Aug 201937012Highwire
Sep 201923010Highwire
Oct 201995321Highwire
Nov 20195408Highwire
Dec 201953424Highwire
Jan 202053715Highwire
Feb 20202238Highwire
Mar 202013911Highwire
Apr 202025624Highwire
May 202014122Highwire
Jun 202033124Highwire
Jul 2020174217Highwire
Aug 202043120Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.nn.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Letters

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Letters Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Advertisement